Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.
Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. Temesgen Z, et al. Among authors: kenderian ss. medRxiv [Preprint]. 2020 Jun 14:2020.06.08.20125369. doi: 10.1101/2020.06.08.20125369. medRxiv. 2020. Update in: Mayo Clin Proc. 2020 Nov;95(11):2382-2394. doi: 10.1016/j.mayocp.2020.08.038 PMID: 32587983 Free PMC article. Updated. Preprint.
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.
Ruella M, Barrett DM, Kenderian SS, Shestova O, Hofmann TJ, Perazzelli J, Klichinsky M, Aikawa V, Nazimuddin F, Kozlowski M, Scholler J, Lacey SF, Melenhorst JJ, Morrissette JJ, Christian DA, Hunter CA, Kalos M, Porter DL, June CH, Grupp SA, Gill S. Ruella M, et al. Among authors: kenderian ss. J Clin Invest. 2016 Oct 3;126(10):3814-3826. doi: 10.1172/JCI87366. Epub 2016 Aug 29. J Clin Invest. 2016. PMID: 27571406 Free PMC article.
Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes.
Anagnostou T, Sakemura R, Forsman CL, Patnaik MS, Paludo J, Gastineau DA, Buadi FK, Porrata LF, Kumar SK, Gertz MA, Lacy MQ, Dispenzieri A, Gonsalves WI, Lehman JS, Hogan WJ, Hashmi SK, Alkhateeb H, Shah MV, Litzow MR, Kenderian SS. Anagnostou T, et al. Among authors: kenderian ss. Bone Marrow Transplant. 2020 Sep;55(9):1879-1881. doi: 10.1038/s41409-020-0851-3. Epub 2020 Mar 11. Bone Marrow Transplant. 2020. PMID: 32161319 No abstract available.
CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.
Mohty M, Dulery R, Gauthier J, Malard F, Brissot E, Aljurf M, Bazarbachi A, Chabanon C, Kharfan-Dabaja MA, Savani BN, Huang H, Kenderian SS, Perales MA, Yakoub-Agha I, Nagler A. Mohty M, et al. Among authors: kenderian ss. Bone Marrow Transplant. 2020 Aug;55(8):1525-1532. doi: 10.1038/s41409-020-0892-7. Epub 2020 Apr 18. Bone Marrow Transplant. 2020. PMID: 32305998 Review.
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
Heybeli C, Sridharan M, Alkhateeb HB, Villasboas Bisneto JC, Buadi FK, Chen D, Dingli D, Dispenzieri A, Gertz MA, Go RS, Hashmi SK, Hayman SR, Hogan WJ, Inwards DJ, Kenderian SS, Kumar SK, Litzow MR, Porrata LF, Lacy MQ, Micallef IN, Patnaik MM, Shah MV, Leung N. Heybeli C, et al. Among authors: kenderian ss. Am J Hematol. 2020 Oct;95(10):1170-1179. doi: 10.1002/ajh.25922. Epub 2020 Aug 8. Am J Hematol. 2020. PMID: 32618000 Free article.
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Hampel PJ, et al. Among authors: kenderian ss. Blood Cancer J. 2021 Mar 2;11(3):47. doi: 10.1038/s41408-021-00443-1. Blood Cancer J. 2021. PMID: 33654067 Free PMC article. No abstract available.
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.
Sakemura R, Hefazi M, Siegler EL, Cox MJ, Larson DP, Hansen MJ, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Ruff MW, Nevala WK, Walters DK, Parikh SA, Lin Y, Jelinek DF, Kay NE, Bergsagel PL, Kenderian SS. Sakemura R, et al. Among authors: kenderian ss. Blood. 2022 Jun 30;139(26):3708-3721. doi: 10.1182/blood.2021012811. Blood. 2022. PMID: 35090171 Free PMC article.
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
Alkhateeb HB, Mohty R, Greipp P, Bansal R, Hathcock M, Rosenthal A, Murthy H, Kharfan-Dabaja M, Bisneto Villasboas JC, Bennani N, Ansell SM, Patnaik MM, Litzow MR, He R, Chen D, Al-Kali A, Kenderian SS, Lin Y, Shah MV. Alkhateeb HB, et al. Among authors: kenderian ss. Blood Cancer J. 2022 Jul 26;12(7):113. doi: 10.1038/s41408-022-00707-4. Blood Cancer J. 2022. PMID: 35882844 Free PMC article. No abstract available.
97 results